David M. Goldenberg, a pioneer in radiolabeled antibodies, has received the Society of Nuclear Medicine's 2005 Paul C. Aebersold Award. He has developed antibodies for various cancer types and therapies, making significant contributions to nuclear medicine.
SourceSociety of Nuclear Medicine and Molecular Imaging·DateJun 19, 2005
Larson, a leading expert in targeted radiotherapy and molecular imaging, has made significant contributions to the advancement of positron emission tomography (PET) as a clinical tool for oncology. His research has led to novel findings in cancer understanding and treatment.
SourceSociety of Nuclear Medicine and Molecular Imaging·DateJun 19, 2005
David James Brooks, a pioneer in applying PET to movement disorders, received the Kuhl-Lassen Award for his groundbreaking research on Parkinson's and related disorders. His work has improved understanding of disease progression, diagnosis, and therapeutics.
SourceSociety of Nuclear Medicine and Molecular Imaging·DateJun 19, 2005
Apple MacBook Pro 14-inch (M4 Pro)
Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.
Researchers at USC College of Letters, Arts and Sciences have found a link between early exposure to inflammatory diseases like gum disease and an increased risk of Alzheimer's. The study, which analyzed data from the Swedish Twin Registry, suggests that chronic gum disease may be a preventable risk factor for Alzheimer's, adding to th...
Researchers have successfully derived human embryonic stem cells that can develop into primordial germ cells, which eventually form eggs and sperm. This breakthrough may help solve infertility issues and study the effects of environmental chemicals on reproductive development. Further work is needed to translate this promise into reality.
SourceEuropean Society of Human Reproduction and Embryology·DateJun 19, 2005
A new computer program, HipMask, uses brain scans to predict future Alzheimer's disease, offering a possible tool for early screening. The technique measures metabolic activity in the hippocampus, which diminishes in size as Alzheimer's progresses.
SourceNYU Langone Health / NYU Grossman School of Medicine·DateJun 19, 2005